Tissue factor pathway inhibitor 2 as a serum marker for diagnosing asymptomatic venous thromboembolism in patients with epithelial ovarian cancer and positive D-dimer results.

Miyake, Ryuta; Yamada, Yuki; Yamanaka, Shoichiro; Kawaguchi, Ryuji; Ootake, Norihisa; Myoba, Shohei; Kobayashi, Hiroshi

Miyake, Ryuta; Yamada, Yuki; Yamanaka, Shoichiro; Kawaguchi, Ryuji; Ootake, Norihisa; Myoba, Shohei; Kobayashi, Hiroshi.

Afiliación

Miyake R; Department of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara 634-8522, Japan.
Yamada Y; Department of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara 634-8522, Japan.
Yamanaka S; Department of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara 634-8522, Japan.
Kawaguchi R; Department of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara 634-8522, Japan.
Ootake N; Bioscience Division, Research and Development Department, Tosoh Corporation, Ayase-shi, Kanagawa 252-1123, Japan.
Myoba S; Bioscience Division, Research and Development Department, Tosoh Corporation, Ayase-shi, Kanagawa 252-1123, Japan.
Kobayashi H; Department of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara 634-8522, Japan.

Mol Clin Oncol ; 16(2): 46, 2022 Feb.

Article en En | MEDLINE | ID: mdl-35003744

Palabras clave

D-dimer; ovarian cancer; tissue factor pathway inhibitor 2; venous thromboembolism

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Mol Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google